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Extensive  studies  in  the  mouse  have shown  that  cell-mediated  lympholysis can 
occur against virus-infected (1) or chemically modified (2) target cells if the cytolytic 
effector cell shares an H-2 determinant with the target cell. The same holds true for 
the minor histocompatibility antigens such as H-Y (3,  4).  More recent studies have 
shown that the same phenomenon can be observed in man. Our group has described 
a  patient  (Mrs.  R.)  suffering from aplastic anemia whose lymphocytes were able to 
kill  the  lymphoeytes of her  HLA-identical  brother  and  all  other  HLA-A2-positive 
males  (5).  Cells  from  HLA-A2-negative  males  and  all  females  (with  two  possible 
exceptions, vide infra)  were not killed. 
When the serum of Mrs. R. (serum R.) 1 was tested for the presence of lympholytic 
antibodies it was found that complement-dependent cytolytic antibodies were present 
that  reacted  with  part  of the  cells  stained  with  anti-Ig fluorescein  isothiocyanate 
(FITC).  It appeared ,possible that  this antibody recognized a  hitherto  undescribed, 
possibly non-HLA specificity. 
In this article we will describe the results obtained so far with the serum R. This 
serum demonstrates the presence of an antibody with an almost perfect correlation 
with  HLA-A2-restricted  H-Y killing  in  the  cell-mediated  lympholysis  (CML)  test 
described by Goulmy et al. (6). This serum is unique because it is the first example of 
an HLA-A2-restricted antibody directed against a  non-HLA antigen.  We will show 
furthermore  that  this  serum  reacts  only  with  part  of the  mononuclear  cells  from 
peripheral blood and that the antibody in it can be found in the IgM fraction. 
Materials and Methods 
Serum. The serum R. used for the experiments was obtained from a female patient suffering 
from apiastic anemia. She was 46 yr old and married. From five pregnancies, two boys and 
three girls were delivered.  From March 25th,  1975 until April 25th,  1975 she received  19 buffy 
coat-free blood transfusions and from March  14th, 1975 until May 1st, 1975, she received 40 
platelet transfusions. 
* Supported in part by the National Institutes of Health contract 1-AI-82553, the Dutch Organization 
for Health Research (TNO), the Dutch Foundation for Medical Research (FUNGO), which is subsidized 
by the Dutch Organization for the Advancement of Pure Research (ZWO), and the J. A. Cohen Institute 
for Radiopathology and Radiation Protection. 
1 Abbreviations used in thispaper: ALG, anti-lymphocyte globulin; BSA, bovine serum albumin; CML, cell- 
mediated lympholysis;  CTL, cytotoxic T  lymphocytes; FITC, fluorescein  isothiocyanate; NIH, National 
Institutes of Health; PBS,  phosphate-buffered saline;  serum R., serum from a  female patient, Mrs.  R., 
suffering from aplastic anemia; TCF, two-color fluorescence. 
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From these platelet transfusions,  36 were donaled by male donors.  Her HLA type is HLA- 
A2,  B40,  Bw6, Cw3,  DRw6/A2,  BI2,  Bw4,  DRw4.  On  May  9th,  1975  she  received a  bone 
marrow graft from her HLA-identical brolher after anti-lymphocyte globulin (ALG) pretreat- 
ment. There was a temporary take, but the graft was rejected after 20 d. The serum we used for 
the experiments to be described, however, was obtained before the bone marrow transplantation. 
Cells.  Mononuclear cells were obtained from tILA-A, -B, -C, and -DR typed healthy panel 
donors and from healthy family members. From each donor, 3-5 ml heparin blood was drawn, 
diluted  with  an equal  amount  of phosphate-buffered  saline  (PBS)  and  after  layering over a 
Ficoll-Isopaque (Pharmacia  Fine Chemicals,  Div. of Pharmaeia,  Inc.,  Piscataway,  N. J.)  (7) 
gradient  (density,  1.077),  the  tubes  were centrifuged  for  15  min  at  1,000  g.  The  cells in the 
interface were, after washing with PBS-1% bovine serum albumin (BSA) used in the two-color 
fluorescence (TCF) method as described by van Rood et al. (8) with a  few modifications. As a 
screening method, we used a  microtest in HAMAX plates (Moss, Norway). Because only part 
of the cells reacted, the results could only be evaluated by counting the percentage of the cells 
that had been lysed. For that  reason a  macro TCF method was used. 
Macro TCF Test.  The test was performed as  follows: two drops  (:t:  0.05  ml)  of antiserum 
were incubated with  1 or 2 million mononuclear cells. These cells were labeled (in a  volume of 
0.5  ml)  for 5  min  at  37°C  with  FITC-labeled anti-Ig  (Behring-Werke  AG, Marburg/Lahn, 
West Germany)  diluted  1:3 with  PBS in  a  silieonized test  tube  (8  ×  0.8  cm)  for 60 min  at 
20°C. After this incubation  time,  10 drops of rabbit  complement were added,  the suspension 
carefully mixed with a  Pasteur capillary pipette, and incubated again for 2 h at 20°C. 
Finally, two drops of ethidium bromide,  1:70 dilution in 5% EDTA in PBS of a concentrated 
solution (100 p,g/ml) were added, gently mixed with a Pasteur pipette, incubated for 15 rain at 
room temperature and the tube was centrifuged for 5 min at 600 g. The supernate was removed 
and  the  sediment  was  transferred  to  a  slide  and  covered with  a  coverglass.  With  a  normal 
microscope (Carl Zeiss, Oberkochen, West Germany) with a  two-wavelength illuminator after 
Ploem (9), and 500  ×  magnification 200 to 300 cells were evaluated. 
As  a  control,  AB  serum  from  a  nontransfused,  healthy  male  donor  was  used.  In  a  TCF 
preparation, one can identify T  cells (not labeled by the anti-Ig-FITC; these cells can thus only 
be seen with phase contrast)  and monocytes (small green spots on the membrane; these cells do 
not  cap  under  the  conditions  described  above),  and  B  cells  (green  caps,  and  occasional 
interrupted  green lines). When a  cell is dead the ethidium  bromide stains the nucleus with a 
red fluorescence. The green and red fluorescence can be seen simultaneously by appropriate use 
of filters (8). 
National Institutes of Health  (NIH)  Cytotoxicity Method.  We used  the normal  standard  NIH 
method  as  described  in  the  manual  of tissue-typing  techniques  (10).  The  method  used  was, 
briefly:  serum  and  cells were incubated  for 30  rain  at  room  temperature  in  a  micro-culture 
tissue plate (catalog No.  1/5682;  C. A. Greiner und Sfhn, West Germany)  under paraffin oil. 
Then normal rabbit complement was added and the mixture was incubated for another 60 rain 
at room temperature.  The reading was done with an inverted phase-contrast  microscope after 
the addition of eosin and after formalin fixation. 
Serum Absorptions.  Frozen  mononuclear  cells  obtained  from  several  (five-six)  donors  as 
described above and pooled, were used for absorption of serum R. 40 million cells were used to 
absorb  0.1  ml serum.  All absorptions  were done at room temperature.  The lymphocytes were 
divided into aliquots and spun for 10 rain at 20,000 g. The serum was added to the dry sediment 
in the first tube,  mixed well, incubated  for 30 min, and centrifuged.  The supernatant  serum 
was aspirated  and added to the second tube with lymphocytes, mixed again, incubated  for 30 
min, and centrifuged. The absorbed serum was stored at -20°C  until further use. 
Indirect Immunofluorescence.  One drop  (+  0.025  ml)  serum and one drop  mononuclear cells 
containing 0.5-1  million cells were incubated  in a  silieonized glass tube  (8  ×  0.8 cm)  for 30 
min at  20°C.  The sediment was washed  three times with  PBS-I% BSA, and  then  incubated 
with one drop  of the F(ab')2  preparation  of a  tetramethyl  rhodamine  isothiocyanate-labeled 
goat anti-human  IgG (Fc), or one drop of the F(ab')2 preparation ofa FITC-labeled goat anti- 
human  anti  IgM  (Fc), or one drop of FITC-labeled goat  anti-human  anti  IgA  (Fc)  (Nordic, 
Tilburg, The Netherlands). 
Marking of Monocytes with  Latex.  5  ml  heparin  blood  was  shaken  for  30  min  in  a  37°C 
waterbath with 0.05 ml latex suspension (1-4  ×  10 x° particles per ml, DIFCO-BACTOLATEX A. VAN LEEUWEN,  E. GOULMY,  AND J. J.  VAN ROOD  1077 
0.81, Difco Laboratories, Detroit, Mich.). Then the blood was diluted with an equal volume of 
PBS and layered on Ficoll-Isopaque. Subsequently the tubes were spun for 15 min at  1,200 g. 
The cells from the interface were washed twice with PBS-I% BSA and then incubated for 5 
min at 37°C with FITC-labeled anti-Ig (Behring-Werke AG), diluted  1:3 with PBS. 
Serum Fractionation.  5  ml  of serum  R.  was  fractionated  on  a  Sephadex  G-200  column 
(Pharmacia Fine Chemicals,  Div.  of Pharmacia,  Inc.; 2.5  X  90 era)  and  eluted  with  PBS. 
Fractions  of 99 drops were collected and  the  IgM-, IgG-, and  albumin-rich  fractions were 
pooled. These pools were desalted on a Sephadex G-25 coarse column (2.5  X  45 era) in 0.1 M 
NH4HCOa. The protein-rich void-volume fractions were pooled and lyophilized. For testing in 
the serological assays, the lyophilized pools were dissolved in 1 ml PBS. Particulate matter was 
removed by centrifugation at  5,000 g  for 20 min. The three fractions were also subjected to 
immuno-eleetrophoresis to detect contaminations in the fractions with other Ig. 
Results 
First, we established whether the cells which were killed by serum R. were T  cells, 
B cells, and/or monocytes. From Table I it appears that only a part of the mononuclear 
cells  labeled  with  anti-Ig  was  reacting  with  the  antibody.  The  monocytes  were 
differentiated from the B cells by treatment of the blood with latex. Because serum R. 
did not react with latex-phagocytosing cells, it was concluded that it reacted with the 
B cells only. 
Next, the mononuclear cells of unrelated individuals was reacted with serum R.  14 
cells showed a  kill which was  19% or higher of the Ig-labeled mononuclear cells and 
16 cells (including the patients' own cells) showed a kill of 6% or lower. Of two donors, 
one of which was  Mrs.  R.'s mother,  13%  of the  Ig-labeled  cells  were killed.  It was 
decided  that  if 10%  or less of the cells were killed,  the reaction  would  be scored as 
negative and that if 15% or more were killed, the reaction would be scored as positive. 
A  percentage kill of 10-15% would be considered as doubtful or unclassifiable. 
To determine the optimal temperature  for the reaction in the TCF method, serum 
R. was titrated  in normal AB serum and tested at  10°C, 20°C, and 37°C.  At  10°C, 
only weak  antibody  activity  was  demonstrated.  Incubation  at  37°C  resulted  in  a 
lower titer than incubation at 20°C. Moreover at 37°C a high background of dead T 
cells and monocytes was found. On the basis of these findings all  tests were done at 
20°C.  Serum  R.  did  not  contain  an  autologous  antibody  as  was  demonstrated  by 
testing the serum with Mrs. R.'s own cells. 
From serum  R.  IgM-,  IgG-, and  albumin-rich  fractions were prepared.  Table  II 
shows the results of the reactions with  HLA-A2-positive male and HLA-A2-positive 
female cells with the IgM, IgG, and albumin serum fractions.  It is apparent  that the 
activity was found in the IgM fraction. This fraction was not completely free of IgG, 
but because the IgG fraction did not react with HLA-A2-positive male cells, we must 
conclude  that  the  antibody  activity  is  located  in  the  IgM  fraction  of the  serum. 
Moreover, we could prove with the indirect immunofluorescence method using F(ab')~ 
fragments of anti-IgM, anti-IgG, and  anti-IgA that  the HLA-A2-positive male cells 
only react with anti-IgM and not with anti-IgG or anti-IgA. 
Several  sera  samples  were  obtained  from  patient  R.  over  a  period  of >1  yr. 
Antibody activity was found in the anti-IgM fraction only (Fig.  1), and declined after 
~1 yr. The antibody was stable at -20°C  for several years. 
When the serum  of Mrs.  R. was tested  in the macro TCF test  against  a  panel of 
unrelated  individuals  consisting  of  14  HLA-A2-positive  male  donors,  7  HLA-A2- 
negative  male  donors,  7  HLA-A2-positive female  donors,  and  4  HLA-A2-negative 1078  MAJOR  HISTOGOMPATIBILITY  COMPLEX-RESTRICTED  ANTIBODY 
TABLE  I 
Distribution of the Cells Killed by Serum R. over the Classes of Mononudear Cells 
Donor  Sex  HLA-A, -B 
Percentage of cytotoxicity 
Mono- 
Anti-Ig la-  cytes (la- 
tex-con-  T  cells  beled cells  taining 
cells) 
% 
H.  ¢~  3, 31, 35, 40  0  1  2 
P.  ~  2, 3, 7,  12  22  1  3 
Z.  6  2,5, 7  43  7  1 
G.  2  9,  12,40  4  1  0 
The cells have been incubated with latex. 
female donors, all the results that typed for HLA-A, -B, -C, and -DR were obtained 
as shown in Table III. The serological data are given in the right-hand column. This 
column indicates the percentage of anti-Ig FITC-labeled cells that were killed. 
An almost perfect correlation between the lysis induced by the lymphocytes of Mrs. 
R. in the CML test and the complement-dependent lysis with the serum of the same 
patient was observed. 
All  HLA-A2-positive male donors  were positive,  and  all  HLA-A2-negative male 
donors were negative. From the HLA-A2-positive female donors, two gave a borderline 
positive reaction (A. J. and M. S., both 13%). The last one is the mother of the patient. 
The HLA-A2-negative female donors all gave negative reactions. 
Comparison of the last two columns from this table show that there exists excellent 
agreement between  the results obtained with the CML method and  those obtained 
with the TCF method. 
Table IV shows the results of the absorption with pools of different cell combina- 
tions. Only HLA-A2-positive males were able to absorb the antibody from the serum. 
The only exception was found when serum R. was absorbed with the lymphocytes of 
the mother. After absorption, no antibody activity was demonstrated anymore in the 
serum R. against an HLA-A2 male donor. 
Discussion 
The complement lymphocytotoxic activity found in serum R. is, in all probability, 
a result of an antibody. This conclusion is based on the findings that it reacted with 
part of the mononuclear cells, recognized a  polymorphic determinant, was stable at 
-20°C  for several years, and could be absorbed by cells carrying the corresponding 
specificities (A2-positive males), but not by other ceils from other donors.  Lastly, the 
antibody activity was shown to be in  the IgM fraction, both on the basis of serum 
fractionation and immunofluorescence studies. To the best of our knowledge, this is 
the first description of an MHC-restricted antibody. 
That  the reaction observed is antibody dependent  appears thus  to be well estab- 
lished. Far less clear is the character of the antigen(s) with which the antibody reacts. 
That the HLA-A2 antigens are involved seems to be certain. The problem lies in the 
definition of the characterization of the other antigen. In the beginning it was thought A. VAS LEEUWEN, E.  GOULMY, AND J. J.  VAN  ROOD 
TABLE  II 
Reactivity of Fractions of Serum R. with Anti-Ig-labeled HLA-A2 Cells in the 
TCF Assay 
Percentage of cytotoxicity of 
Serum  anti-Ig-labeled cells, serum dilu- 
Cell donor  tion:  fractions 
1:1  1:2  l:4  1:8  1:16 
HLA-A2-positive  male 
% 
IgM  20  14  9  6  0 
IgG  0  0  0  0  0 
Albumin  0  0  0  0  0 
HLA-A2-positive  female  IgM  0  0  0  0  0 
IgG  0  0  0  0  0 
Albumin  0  0  0  0  0 
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Fro,  1.  The percentage of positive cells obtained when serum samples from patient R. were tested 
in the indirect immunofluoi'escence  method against a  male HLA-A2-unrelated donor  (M. G.). 
(El), subsequent serum samples of patient R.: IgM is lgM fraction, lgG is IgG fraction. *BM, bone 
marrow transplantation. 
A B  serum 
that this would be the H-Y antigen, which has been shown to be present on human 
male leukocytes (11,  12). The weak reactions with the two female cells were assumed 
to  be  due  to  an  extra  antibody  with  another  specificity.  This  assumption  was 
analogous to the one made by Goulmy et al. (5, 6) when they described the HLA-A2- 
restricted, cell-mediated, anti-H-Y killing of the lymphoeytes of Mrs. R. Then also, a 
few HLA-A2-positive female cells were found which were lysed by Mrs. R.'s lympho- 
cytes, although less strongly than the HLA-A2-positive male cells. The assumption of 1080  MAJOR  HISTOCOMPATIBILITY  COMPLEX-RESTRICTED  ANTIBODY 
TABLE  III 
Correlation between Lysis in the CML Test and Complement-dependent Lysis in Serum R., 
Tested with Several Male and Female Donors all Typed for HLA-A, -B, -C, and -DR. 
Donor  Sex 
HLA  Percentage 
Percentage  of cytotox- 
of specific  icity of the 
anti-Ig-la- 
-A  -B  -Bw4/  -C  -DR  51Cr in the  beled cells 
Bw6  CML test  in the TCF 
method 
H.J.P. 
J.P.  6 
D.B.  d 
K.M.  (3 
T.S.  (3 
O.E.  d 
T.D.  (3 
Z.W.  (3 
M.G.  c~ 
P.K.  (3 
F.C.  (3 
N.O.  (3 
S.T.  6 
S.A.  (3 
E.L  (3 
V. DH.  (3 
H.B,  c3 
D.O.  (3 
A.M.  (3 
j.P.  (3 
V.R.  (3 
A.J.  <2 
M.S.*  <2 
K.P.  <2 
W.I. 
K.A.  <2 
R.,  <2 
A. V.L.  <2 
B.G.  <2 
A.M.  <2 
D.I.  <2 
H.O.  <2 
%  % 
2, 3  7,  12  4, 6  --  2, 6  +47  22 
2, 3  7, 40  6, 6  3  2  +41  32 
1, 2  8, 40  6, 6  3  1, 3  +44  37 
2, 2  12, 4  4, 6  3  4, 6  +63  33 
1, 2  8, 27  4, 6  2  2, 3  +46  38 
2,  11  15, 40  6, 6  4  4,  (5  ×  8)  +33  25 
1,2  8,40  6,6  --  7  +28  19 
2  5, 7  4, 6  --  2, 4  86  43 
2  8,  15  6, 6  3  3, 4  ND  29 
1, 2  8, 21  6, 6  6  3, 7  ND  25 
2, 32  15, 40  6, 6  3  4, 8  ND  30 
2, 31  5, 40  4, 6  3  2, (4  ×  7)  ND  36 
2, 30  7, 39  6, 6  --  1, 5  ND  19 
2, 2  7, 35  6, 6  4  1, 8  ND  23 
11,31  15,  17  4,6  3  4,7  -1  0 
3, 31  35, 40  6,6  3,4  1,4  +9  0 
11, 29  8,  15  4, 6  3  3, 4  -2  1 
3  18, 27  4,6  2,3  4  -3  2 
1, 3  7, 8  6, 6  --  3, 6  +6  0 
1,  10  8,  12  4, 6  --  1, 3  ND  0 
1, 33  17, 18  4, 6  --  5, 7  ND  1 
2, 9  5, 40  4, 6  3  4  +  15  13 
2, 31  12, 35  4, 6  4  1, 4  4  13 
1, 2  8,  12  4, 6  5,  2, 6  +3  5 
2, 3  7, 40  6, 6  3  1, 4  -1  2 
2, 32  8,  15  6, 6  3  6, 8  -3  0 
2,2  12,40  4,6  3  4,6  -1  1 
2, 32  15  4, 6  3  4,  (5  ×  8)  ND  6 
9  12, 40  4, 6  3  6, (5  ×  8)  +6  4 
1,9  8,40  6,6  3  1,3  0  4 
3, 26  35  6,6  4  1,(4  X  7)  +1  4 
10,28  35, 53  4,6  4  3, (5  ×  8)  0  5 
ND, not done. 
* Mother of patient. 
:~ Patient (Mrs. R.). 
the  existence  of a  weak  extra  antibody  becomes,  however,  rather  unlikely  because  at 
least  one  of these  female  cells was  able  to  absorb  all  antibody  reactivity  against  the 
male  A2-positive  cells  from  the  serum.  We  could  assume  the  presence  of two  poten- 
tiating  or complementing  antibodies,  one  an  anti,HLA-A2  and  the other  an  anti-H- 
Y.  One  would  then  have  to  postulate  that,  with  a  few exceptions,  only  when  a  cell 
presents  both  the  HLA-A2  and  H-Y  antigen  will  lysis occur.  Occasionally,  an  HLA- 
A2-positive  female  cell  will  be  lysed by  the  anti-HLA-A2  alone.  This  explanation  is, A. VAN LEEUWEN, E. GOULMY, AND J. J. VAN ROOD 
TABLE IV 
Reactivity of Serum R. with HLA-A2 Male Lymphocytes after Absorption 
with Various Lymphocyte Pools* 
Percentage of cytotoxic- 
Lymphocyte pool  ity of anti-Ig-labeled 
cells* 
% 
HLA-A2-positive  males  2 
HLA-A2-negative  males  27 
HLA-A2-positive  females  27 
HLA-A2-positive  females  26 
* Each pool consists of cells from five to six individuals. 
The percentage of cytotoxicity  of anti-Ig-labeled  cells before absorption was 
29%. 
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in all probability, incorrect because we then expect that HLA-A2-negative males and 
HLA-A2-positive females would be able to absorb the antibody, and this appears not 
to be the case (Table IV). 
Furthermore, Mrs. R. is HLA-A2 homozygous positive, which almost excludes the 
possibility that she can make an anti-HLA-A2 antibody. A  possibility which cannot 
be ruled out is that the non-HLA antigen is not coded for by the H-Y chromosome, 
but  by  an  autosomal  chromosome  that  is  involved  in  either  the  development  of 
maleness  or  the  expression  of H-Y.  This  explanation  is  not  very satisfying  either 
because it would imply that the two females, A. J. and M. S., would be, in this regard, 
different from the other four HLA-A2-positive females and we have no evidence for 
this. 
It is clear that serum R. should not only be studied by cytotoxicity, but by other 
techniques as well. We have started such a  study with immunofluorescence. (Fig.  1). 
More-sensitive techniques,  including  cell-surface-labeling techniques,  will be nec- 
essary to study not only the distribution of the antigen(s) involved, but the character 
of the antigen as well. If we assume on the basis of the absorption experiments that 
only one  antibody  is  responsible,  then  logically  the  next  question  is  whether  this 
antibody reacts with an antigen  that arises through an interaction of HLA-A2 with 
the  non-HLA  antigen  (whether  this  is  H-Y  or  something  else  is,  in  this  context, 
irrelevant)  or  whether  the  simultaneous  presence  of  HLA-A2  and  the  non-HLA 
antigen in the same cell induces a  neo-antigen. 
The  striking  similarity  of  the  results  in  the  CML  test  and  the  complement- 
dependent cytotoxicity test shown in Table III raises the question, which cannot yet 
be answered: What is the relation of the antigen recognized by the antibody vis-a-vis 
the determinant interacting with the cytolytic cell? 
The apparent contradiction of the good correlation between the serological detec- 
tion of a  polymorphic antigen  present  on part of the B  cells and  the killing in  the 
CML test  of phytohemagglutinin  blasts which  are thought  to arise predominantly 
from T  cells becomes understandable in the light of our finding that the antigen can 
be shown to be present on T  cells by immunofluorescence (A. van Leeuwen and J. J. 
van Rood. Manuscript in preparation.). 
It should  be of interest  to  look for H-Y antibodies  in  the  sera of other patients 
whose  lymphocytes show  an  HLA-restricted,  anti-H-Y  CML  killing  and  for  that 1082  MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED ANTIBODY 
matter in the sera of all patients whose lymphocytes show a direct positive CML test. 
One could even speculate that (some) CML reactions are a result of similar antibodies 
and  are  thus  in  fact  not  cytotoxic  T  lymphocytes  but  antibody-dependent  cell- 
mediated  cytotoxicity  reactions.  This  seems,  however,  unlikely  because  the  CML 
reactions are done with three-times-washed lymphocytes in the absence of serum from 
patients.  Furthermore,  ,absorptions  on  monolayers  demonstrated  the  clonality  of 
cytotoxic T  lymphocytes with MHC-restricted, anti-H-Y specificity (13).  It is, in this 
context,  appropriate to emphasize that  we would  have missed  the  antibody  in  the 
serum of Mrs.  R.  if we had not  used the TCF test that enabled us to detect  that a 
small part of the mononuclear cells from peripheral blood were killed. 
Preliminary  results with cells from patients with abnormal chromosome patterns 
have provided already interesting information on sexual differentiation. It might well 
be that this serum and other similar ones might open new avenues in immunogenetics 
and  might  be essential  in  the  unraveling of the altered-self versus dual-recognition 
dilemma by immunological methods. 
Summary 
An IgM antibody, present in the serum of a  female patient with aplastic anemia, 
is described that reacted in a modified complement-dependent cytotoxicity test with 
a subset of the B cells from HLA-A2-positive, but not HLA-A2-negative males. With 
the exception of two HLA-A2-positive females, the antibody did not react with other 
cells  from either  HLA-A2-positive or  HLA-2-negative females.  The  cells  of one of 
these and  from HLA-A2-positive males were able to absorb the  antibody from the 
serum. Cells from other donors were unable to absorb the antibodies. 
The  mononuclear cells of the  same patient  were cytolytic  in  cell-mediated  lym- 
pholysis (CML)  for phytohemagglutinin blasts from all HLA-A2-positive males and 
one of the females reacting with antibody, but not with blasts from HLA-A2-negative 
males  and  all  other  females.  Thus,  the  results  obtained  with  the  antibody  in  the 
complement-dependent  cytotoxicity test  showed  an  almost perfect correlation  with 
cytolysis in CML tests. 
These results suggest that the IgM antibody may be the first example with major 
histocompatibility complex restriction.  Because  the  antibody reacted with  the  cells 
from two female donors, the restricting determinant is not, in all probability, the H- 
Y determinant. 
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